“…However many of the new targeted agents interfere with constitutively active survival pathways or initiate apoptosis by directly influencing proapoptotic signals (Citri et al, 2004;Kim et al, 2005;Larsen et al, 2011;Vega et al, 2009;Zhang et al, 2009). In addition autophagic cell death and programmed necrosis are being actively investigated as alternative and pharmacologically relevant forms of programmed cell death (Berghe et al, 2010;Bijnsdorp et al, 2011;Duan et al, 2010;Gozuacik & Kimchi, 2007;McCall, 2010;Notte et al, 2011;Paglin et al, 2005;Platini et al, 2010). Combination studies should be conducted using effect biomarkers that are as close as possible to the known mechanisms targeted by single agents, and biomarkers specifically related to druginduce tumor cell death appear more adequate for the assessment of new targeted agents (Cameron et al, 2001;Facoetti et al, 2008;Wesierska-Gadek et al, 2005).…”